Globus Medical shares the details from their earnings call for the second quarter of 2026.

Oct 12, 2026, 6:29 AM ETResultsRead the original at Benzinga

Good for GMED

Globus Medical's sales rose 6% and profit per share rose 56%, and it raised its 2026 profit-per-share forecast. Sales rose 9% excluding Nevro, showing the growth rate differs by measure, but reported sales also increased.

GMED · Globus Medical

AI read · Good for GMED

The AI's read

The results point to gains in sales and profit across several parts of the business. The company also raised its 2026 profit-per-share forecast. Sales growth was 6% as reported and 9% excluding Nevro, so the growth rate differs by measure, but both figures increased.

Get alerts for GMED

Follow Globus Medical (GMED) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for GMED

Free on the App Store and Google Play, or on the web.